Bonnie L Bassler Royalty Pharma PLC (RPRX) insider trading activity

RPRX Quotes by TradingView

Bonnie L Bassler is Director of Royalty Pharma plc. Currently has a direct ownership of 59,796 shares of RPRX, which is worth approximately $1.57 Million. The most recent transaction as insider was on Sep 30, 2024, when has been sold 1,342 shares (Class A Ordinary Shares) at a price of $27.92 per share, resulting in proceeds of $37,468. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 59.8K
2.3% 3M change
32.38% 12M change
Total Value Held $1.57 Million

Bonnie L Bassler Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 30 2024
BUY
Grant, award, or other acquisition
$37,468 $27.92 p/Share
1,342 Added 2.2%
59,796 Class A Ordinary Shares
Jun 28 2024
BUY
Grant, award, or other acquisition
$37,493 $26.8 p/Share
1,399 Added 2.34%
58,454 Class A Ordinary Shares
Jun 07 2024
BUY
Grant, award, or other acquisition
-
9,293 Added 14.01%
57,055 Class A Ordinary Shares
Mar 28 2024
BUY
Grant, award, or other acquisition
$37,485 $30.23 p/Share
1,240 Added 2.53%
47,762 Class A Ordinary Shares
Dec 29 2023
BUY
Grant, award, or other acquisition
$37,491 $27.71 p/Share
1,353 Added 2.83%
46,522 Class A Ordinary Shares
Sep 29 2023
BUY
Grant, award, or other acquisition
$37,478 $27.08 p/Share
1,384 Added 2.97%
45,169 Class A Ordinary Shares
Jun 30 2023
BUY
Grant, award, or other acquisition
$37,484 $31.03 p/Share
1,208 Added 2.68%
43,785 Class A Ordinary Shares
Jun 23 2023
BUY
Grant, award, or other acquisition
-
7,747 Added 15.39%
42,577 Class A Ordinary Shares
Mar 31 2023
BUY
Grant, award, or other acquisition
$37,480 $35.73 p/Share
1,049 Added 2.92%
34,830 Class A Ordinary Shares
Dec 30 2022
BUY
Grant, award, or other acquisition
$37,493 $39.76 p/Share
943 Added 2.72%
33,781 Class A Ordinary Shares
Sep 30 2022
BUY
Grant, award, or other acquisition
$37,488 $41.06 p/Share
913 Added 2.71%
32,838 Class A Ordinary Shares
Jun 30 2022
BUY
Grant, award, or other acquisition
$37,493 $41.52 p/Share
903 Added 2.75%
31,925 Class A Ordinary Shares
Jun 24 2022
BUY
Grant, award, or other acquisition
-
6,328 Added 16.94%
31,022 Class A Ordinary Shares
Mar 31 2022
BUY
Grant, award, or other acquisition
$37,471 $38.87 p/Share
964 Added 3.76%
24,694 Class A Ordinary Shares
Dec 31 2021
BUY
Grant, award, or other acquisition
$37,467 $39.11 p/Share
958 Added 3.88%
23,730 Class A Ordinary Shares
Sep 30 2021
BUY
Grant, award, or other acquisition
$37,498 $37.8 p/Share
992 Added 4.17%
22,772 Class A Ordinary Shares
Jun 30 2021
BUY
Grant, award, or other acquisition
$37,488 $43.04 p/Share
871 Added 3.85%
21,780 Class A Ordinary Shares
Jun 25 2021
BUY
Grant, award, or other acquisition
-
5,726 Added 21.5%
20,909 Class A Ordinary Shares
Mar 31 2021
BUY
Grant, award, or other acquisition
$37,454 $45.9 p/Share
816 Added 5.1%
15,183 Class A Ordinary Shares
Dec 31 2020
BUY
Grant, award, or other acquisition
$37,466 $45.69 p/Share
820 Added 5.4%
14,367 Class A Ordinary Shares
Sep 30 2020
BUY
Grant, award, or other acquisition
$37,465 $41.17 p/Share
910 Added 6.29%
13,547 Class A Ordinary Shares

Also insider at

REGN
REGENERON PHARMACEUTICALS, INC. Healthcare
Director
CDTX
Cidara Therapeutics, Inc. Healthcare
Director
KLDO
Kaleido Biosciences, Inc. Healthcare
Director
BLB

Bonnie L Bassler

Director
Tarrytown, NY

Track Institutional and Insider Activities on RPRX

Follow Royalty Pharma plc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RPRX shares.

Notify only if

Insider Trading

Get notified when an Royalty Pharma PLC insider buys or sells RPRX shares.

Notify only if

News

Receive news related to Royalty Pharma plc

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on RPRX